Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus- immortalized B lymphocytes

Blood

Volumn 88, Issue 8, 1996, Pages 3147-3159

  Pomponi, Fabrizio ^a   Cariati, Roberta ^a   Zancai, Paola ^a   De Paoli, Paolo ^a   Rizzo, Silvana ^a   Tedeschi, Rosa Maria ^a   Pivetta, Barbara ^a   De Vita, Salvatore ^a   Boiocchi, Mauro ^a   Dolcetti, Riccardo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; MOFAROTENE; RETINOID;

ARTICLE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION;

EID: 10244235416     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.3147.bloodjournal8883147     Document Type: Article

References (40)

1. Mangelsdorf DJ, Kliewer SA, Kakizuka A, Umesono K, Evans RM: The retinoid receptors, in Sporn M, Roberts AB, Goodman DS (eds): The Retinoids. Biology, Chemistry and Medicine. New York, NY Raven, 1995, p 319
2. Allegreto EA, McClurg MR, Lazarchik SB, Clemm DL, Kerner SA, Elgort MG, Bohem MF, White SK, Pike JW, Heyman RA: Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism. J Biol Chem 268:26625, 1993
3. Warrell RP Jr: Applications for retinoids in cancer therapy. Semin Hematol 31:1, 1994
4. Benner SE, Lippman SM, Hong WK: Retinoid chemoprevention of second primary tumors. Semin Hematol 31:26, 1994
5. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All-wans retinoic acid as a differentiation therapy for acute promyelocytic leukemia I. Clinical results. Blood 76:1704, 1990
6. Warrell RP Jr, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrowsky E: Differentiation therapy for acute promyelocytic leukemia with Tretinoin (all-trans retinoic acid). N Engl J Med 324:1385, 1991
7. Lippman SM, Kavanagh JJ, Paredes-Espinosa M: 13-Cis retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84:241, 1992
8. Lippman SM, Meyskens FL: Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 107:499, 1987
9. Kessler JF, Jones SE, Levine N, Lynch PJ, Booth AR: Isotretinoin and cutaneous helper-T-cell lymphoma (mycosis fungoides). Arch Dermatol 123:201, 1987
10. Hoting E, Meissner K: Arotinoid-ethylester: Effectiveness in refractory cutaneous T-cell lymphoma. Cancer 62:1044, 1988
11. French LE, Ramelet AA, Saurat J-H: Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin. Lancet 344:686, 1994
12. Avilés A, Guzmán R, Garcia EL, Diaz-Maqueo JC: Biological modifiers (etretinate and interferon alfa 2a) in the treatment of refractory cutaneous T-cell lymphoma. Cancer Biother 11:21, 1996
13. Abb J, Deinhardt F: Effects of retinoid acid on the human lymphocyte response to mitogens. Exp Cell Biol 48:169, 1980
14. 2+ currents and cell proliferation in a B-lymphocyte cell line. J Cell Physiol 135:317, 1988
15. Buck J, Dannecker L, Viswanathan K, Cohen SL, Chait BT, Hämmerling U: Retinol is essential for growth of activated human B cells. J Exp Med 171:1613, 1990
16. Buck J, Myc A, Garbe A, Cathomas G: Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes. J Cell Biol 115:851, 1991
17. Blomhoff HK, Smeland EB, Erikstein B, Rasmussen AM, Skrede B, Skjønsberg C, Blomhoff R: Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem 25:23988, 1992
18. Fahlman C, Jacobsen SE, Smeland EB, Lømo J, Næss CE, Funderud S, Blomhoff HK: All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. J Immunol 155:58, 1995
19. Nilsson K, Giovannella BC, Stehlin JS, Klein G: Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 19:337, 1977
20. Calendar A, Billaud M, Aubry J, Banchereau J, Vuillaume M, Lenoir G: EBV induces expression of B cell activation markers on in vitro infection of EBV negative B lymphoma cells. Proc Natl Acad Sci USA 84:8060, 1987
21. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E: Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMPI cooperatively induce CD23. J Virol 64:2309, 1990
22. Cohen JI, Wang F, Kieff E: Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol 65:2545, 1991
23. Kaye KM, Isuzmi KM, Kieff E: Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150, 1993
24. Nalesnik MA, Jaffe R, Starzi TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J: The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173, 1988
25. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI: Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080, 1989
26. Miller G, Lipman M: Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190, 1973
27. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
28. Dolcetti R, Frisan T, Palmieri G, Rizzo S, Maestro R, Santoni A, Boiocchi M: In vivo phenolypic characteristics of AKR T-cell lymphomas with different leukemic potential: Possible role of α4β7 integrin in the progression towards the leukemic phenotype. Int J Cancer 56:560, 1994
29. Polyak K, Kato J-Y, Solomon MJ, Sherr CJ, Massagué J, Roberts JM, Koff A: p27Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9, 1994
30. Eliason JF, Kaufmann F, Tanaka T, Tsukaguchi T: Antiproliferative effects of the arotinoid Ro40-8757 on human cancer cell lines in vitro. Br J Cancer 67:1293, 1993
31. Crettaz M, Baron A, Siegenthaler G, Hunziker W: Ligand specificities of recombinant retinoid acid receptors RAR-alpha and RAR-beta. Biochem J 272:391, 1990
32. Adamson PC: Pharmacokinetics of all-trans-retinoic acid: Clinical implications in acute promyelocytic leukemia. Semin Hematol 31:14, 1994 (suppl 5)
33. Schroder EW, Rapaport E, Kabcenell AK, Black PH: Growth inhibitory and stimulatory effects of retinoic acid on murine 3T3 cells. Proc Natl Acad Sci USA 79:1549, 1982
34. Marth C, Böck G, Daxenbichler G: Effect of 4-hydroxyphenyl-retinamide and retinoid acid on proliferation and cell cycle of cultured human breast cancer cells. J Natl Cancer Inst 75:871, 1985
35. Roberts JM, Koff A, Polyak K, Firpo E, Collins S, Ohtsubo M, Massagué J: Cyclins, Cdks and Cyclin Kinase Inhibitors. Cold Spring Harbor Symposia on Quantitative Biology, vol 59. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory P, 1994, p31
36. Wendel-Hansen V, Rosén A, Klein G: EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation. Int J Cancer 39:404, 1987
37. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743, 1987
38. Delecluse H-J, Kremmer E, Rouault J-P, Cour C, Bornkamm G, Berger F: The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 146:1113, 1995
39. Picchio GR, Kobayashi R, Kirven M, Baird SM, Kipps TJ, Mosier DE: Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res 52:2468, 1992
40. Rochford R, Hobbs MV, Gamier J-L, Cooper NR, Cannon MJ: Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc Natl Acad Sci USA 90:352, 1993